Inhomogeneous Phase Significantly Reduces Oral Bioavailability of Felodipine/PVPVA Amorphous Solid Dispersion
Molecular Pharmaceutics · 02.01.2023 · 20 (1) · 409-418
DOI: 10.1021/acs.molpharmaceut.2c00695 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 19.12.2022. Verfasst von Di Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Minzu University of China, 100081 Beijing, China. Hauptthemen laut MEDLINE: Felodipine, Polymers. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Central University Basic Research Fund of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Inhomogeneity is a key factor that significantly influences the dissolution behavior of amorphous solid dispersion (ASD). However, the underlying mechanisms of the effects of inhomogeneous phase on the dissolution characteristics as well as the bioavailability of ASDs are still unclear. In this study, two types of felodipine/PVPVA based ASDs with 30 wt % drug loading but different homogeneity were prepared: homogeneous "30 wt % ASD" prepared by spray drying, as well as inhomogeneous "30 wt % PM" prepared by physically mixing the sprayed dried 70 wt % ASD with PVPVA. We aimed to investigate (1) drug-polymer interaction mechanism and "apparent" interaction strength within the two ASDs and (2) dissolution mechanism as well as in vivo performance of the two ASDs. DSC thermogram revealing a single Tg in 30 wt % ASD confirmed its homogeneous phase. 1H NMR, FT-IR, and DVS studies collectively proved that strong hydrogen bonding interactions formed between felodipine and PVPVA in ASDs. Moreover, homogeneous "30 wt % ASD" has more numbers of interacting drug-polymer pairs, and thus exhibits stronger "apparent" interaction strength comparing with that of inhomogeneous "30 wt % PM". Unexpectedly,in the in vitro dissolution studies, inhomogeneous "30 wt % PM" showed much faster dissolution and also generated drug concentration ∼4.4 times higher than that of homogeneous "30 wt % ASD". However, drug precipitate recrystallized much slower in homogeneous "30 wt % ASD", presumably because much more polymer coprecipitated with amorphous drug in this system, which helps inhibiting drug crystallization. Surprisingly, homogeneous "30 wt % ASD" showed a significantly higher bioavailability in the in vivo pharmacokinetic studies, with the maximum plasma concentrations (Cmax) and the area under the curve (AUC) values of about 2.7 and 2.3 times higher than those of inhomogeneous "30 wt % PM". The above findings indicated that the amorphous state of drug precipitate contributes significantly to increase bioavailability of ASDs, while traditional in vitro dissolution studies, for instance, if we only compare the dissolved drug in solution or the capability of an ASD to generate supersaturation, are inadequate to predict in vivo performance of ASDs. In conclusion, the phase behavior of ASDs directly impact the formation of drug-polymer interaction, which controls not only drug supersaturation in solution but also drug crystallization in precipitate, and ultimately affect the in vivo performance of ASDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Minzu University of China, 100081 Beijing, China.
- Chengdu Institute of Biology, Chinese Academy of Sciences, 610000 Chengdu, China.
- Key Laboratory of Mass Spectrometry Imaging and Metabolomics (Minzu University of China), State Ethnic Affairs Commission, 100081 Beijing, China.
ORCID-Profile: Yuejie Chen
Förderung
- Central University Basic Research Fund of China
- National Natural Science Foundation of China
Zitieren
APA
Gao, D., Zhu, D., Zhou, X., Dong, S., & Chen, Y. (2023). Inhomogeneous Phase Significantly Reduces Oral Bioavailability of Felodipine/PVPVA Amorphous Solid Dispersion. Molecular Pharmaceutics, 20(1), 409-418. https://doi.org/10.1021/acs.molpharmaceut.2c00695
Vancouver
Gao D, Zhu D, Zhou X, Dong S, Chen Y. Inhomogeneous Phase Significantly Reduces Oral Bioavailability of Felodipine/PVPVA Amorphous Solid Dispersion. Molecular Pharmaceutics. 2023;20(1):409-418. doi:10.1021/acs.molpharmaceut.2c00695
BibTeX
@article{Gao2023,
author = {Gao, Di and Zhu, Dan and Zhou, Xue and Dong, Shuai and Chen, Yuejie},
title = {Inhomogeneous Phase Significantly Reduces Oral Bioavailability of Felodipine/PVPVA Amorphous Solid Dispersion},
journal = {Molecular Pharmaceutics},
year = {2023},
volume = {20},
number = {1},
pages = {409--418},
doi = {10.1021/acs.molpharmaceut.2c00695}
}
EUVIMED